InvestorsHub Logo

JTORENCE

07/13/19 6:05 PM

#267397 RE: loanranger #267395

"Aren't there experienced delayed release pill designers that IPIX could be using?" Of course there are, but they want to be paid in cash, not an IOU for worthless shares /warrants.

steelyeye

07/14/19 11:59 AM

#267412 RE: loanranger #267395

BDD/Novartis/IPIX is a decent connection. Bertolino may add to OR detract from it.



Decent good or just decent? I would ask a grammarian but don't know any decent ones.


Dr. Bertolino held several key positions at Novartis Institutes for Biomedical Research (“NIBR”) from 2008 to 2013, including Vice President of Dermatology and Vice President & Global Head of Translational Medicine for Dermatology. During his time at NIBR, Dr. Bertolino was integral to the marketing approval of Ilaris (canakinumab) in the United States, European Union and Switzerland.



insert-text-here